Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing TitersEshan U. Patel, Oliver Laeyendecker, Aaron A.R. Tobian et al.|Journal of Clinical Microbiology|2020Cited by 198
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma DonorsSarah E. Benner, Andrew D. Redd, Eshan U. Patel et al.|The Journal of Infectious Diseases|2020Cited by 118
National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United StatesWilliam A. Werbel, Jennifer D. Motter, Diane Brown et al.|Clinical Infectious Diseases|2021Cited by 23
Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant RecipientsAndrew H. Karaba, William A. Werbel, Jake D. Kim et al.|medRxiv|2022Cited by 21
Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot StudyBrian J. Boyarsky, Jacqueline Garonzik‐Wang, Michael T. Ou et al.|Transplantation|2021Cited by 20